This week on the Strong New York Podcast, host Kenny Santucci interviews David Watumull, co-founder and CEO of AX3 Life, a longevity company focused on helping people perform at their best for longer. Dave explains the science behind inflammaging — chronic inflammation linked to aging — and how AX3’s bio-pure astaxanthin is designed to address it at the source.Kenny and Dave discuss why astaxanthin is emerging as a foundational daily nutrient for longevity, supporting cognition, heart health, endurance, recovery, and skin and eye health. Dave also breaks down how it works in the body, the growth of research in this space, and clinical findings related to oxidative stress and LDL.They also explore the history of astaxanthin, the challenges of building awareness in the longevity category, and practical details including dosing, packaging, and pricing. A thoughtful conversation on performance, recovery, and the future of longevity science. 00:00 Podcast intro and guest00:25 First look at astaxanthin00:52 How to take it and feel it01:21 Why the pouch packaging02:16 Cellular benefits explained04:00 Research and safety proof05:45 Origin story and setbacks08:10 Marketing and investor hurdles10:51 Elevator pitch and daily stack13:30 Where it comes from and extraction16:41 Awareness and education challenge19:24 Growth channels and target users24:03 Advocates and NIH lifespan study27:23 Where the brand goes next27:48 Astaxanthin with Omega-3s28:53 LDL and Heart Risk31:03 Inflammation and hsCRP32:00 Origin Story and Mission35:55 Dosing and Expectations37:28 Cost and Value Debate39:34 Bioavailability Comparison40:35 Vision for Mass Adoption42:02 Workout Routine and Community46:05 Skin and Exercise Benefits48:26 NAD and Mitochondria50:11 How to Take It Daily51:09 Travel and Fitness in Hawaii53:32 Wrap Up and Where to Buy

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related